Id |
Subject |
Object |
Predicate |
Lexical cue |
T80 |
0-175 |
Sentence |
denotes |
We could see a similar (close to identical) immunogenicity scores for a number of IEDB and 2019-nCov peptides especially for those with high immunogenicity scores ( Figure 2). |
T81 |
176-303 |
Sentence |
denotes |
While all 48 can be potential targets, of particular interest were those having higher immunogenicity score than IEDB peptides. |
T82 |
304-453 |
Sentence |
denotes |
Here, we list 22 out of 48 2019-nCoV peptides that scored higher compared to their targets that have been characterized to be immunogenic ( Table 2). |
T83 |
454-603 |
Sentence |
denotes |
In this list 15 (68%) 2019-nCov peptides have a score higher than 0.5 whereas only 11(50%) of IEDB get a score immunogenicity score greater than 0.5. |